266 related articles for article (PubMed ID: 11945115)
21. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.
Møller N; Jørgensen JO
Endocr Rev; 2009 Apr; 30(2):152-77. PubMed ID: 19240267
[TBL] [Abstract][Full Text] [Related]
22. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
23. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.
Cutfield WS; Wilton P; Bennmarker H; Albertsson-Wikland K; Chatelain P; Ranke MB; Price DA
Lancet; 2000 Feb; 355(9204):610-3. PubMed ID: 10696981
[TBL] [Abstract][Full Text] [Related]
24. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
[TBL] [Abstract][Full Text] [Related]
25. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
26. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.
Wooten N; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2109-14. PubMed ID: 18349057
[TBL] [Abstract][Full Text] [Related]
27. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
Alford FP; Hew FL; Christopher MC; Rantzau C
J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
[TBL] [Abstract][Full Text] [Related]
28. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
29. Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Bunderen CC; van den Dries CJ; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Eur J Endocrinol; 2014 Aug; 171(2):151-60. PubMed ID: 24801587
[TBL] [Abstract][Full Text] [Related]
30. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
31. Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis.
Bismuth E; Chevenne D; Czernichow P; Simon D
Horm Res Paediatr; 2010; 73(6):465-72. PubMed ID: 20407232
[TBL] [Abstract][Full Text] [Related]
32. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury.
Giuliano S; Talarico S; Bruno L; Nicoletti FB; Ceccotti C; Belfiore A
Endocrine; 2017 Oct; 58(1):115-123. PubMed ID: 27878771
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
35. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Yuen KC; Dunger DB
Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
[TBL] [Abstract][Full Text] [Related]
36. Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.
Liang S; Xue J; Li G
Lipids Health Dis; 2018 Apr; 17(1):66. PubMed ID: 29615058
[TBL] [Abstract][Full Text] [Related]
37. GH therapy and cancer risk in hypopituitarism: what we know from human studies.
Pekic S; Popovic V
Eur J Endocrinol; 2013 Nov; 169(5):R89-97. PubMed ID: 23935131
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor I and impaired glucose tolerance.
Dunger D; Yuen K; Ong K
Horm Res; 2004; 62 Suppl 1():101-7. PubMed ID: 15761241
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of growth hormone replacement therapy in adults.
Toogood A
Expert Opin Drug Saf; 2005 Nov; 4(6):1069-82. PubMed ID: 16255665
[TBL] [Abstract][Full Text] [Related]
40. Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study.
Isotton AL; Wender MC; Casagrande A; Rollin G; Czepielewski MA
Eur J Endocrinol; 2012 Feb; 166(2):207-13. PubMed ID: 22108915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
